60
Participants
Start Date
June 30, 2011
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
Inhaled extra-fine hydrofluoalkane-beclomethasone (QVAR)
Infants will be randomized for Inhaled QVAR 100 microgram or placebo twice daily with spontaneous tidal breathing for 30 seconds via aerochamber with face mask for the study period.
RECRUITING
Bnai Zion Medical Center, Haifa
Lead Sponsor
Collaborators (2)
Tel-Aviv Sourasky Medical Center
OTHER_GOV
Schneider Children's Medical Center, Israel
OTHER
Meir Hospital, Kfar Saba, Israel
OTHER
Kaplan Medical Center
OTHER
Barzilai Medical Center
OTHER
Laniado Hospital
OTHER
HaEmek Medical Center, Israel
OTHER
Bnai Zion Medical Center
OTHER_GOV